Pharmacogenetics of asthma

9Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Asthma is a common disease characterized by airway inflammation and bronchorestriction. There are several common categories of medications for treating asthma; however, not all asthmatics have the same response to these medications, some of which are adverse responses that are potentially life threatening. Because interindividual responses to asthma medications can vary considerably, the potential for genetic contributions to variable drug responses is significant. This chapter reviews the most common biological pathways targeted by asthma therapy and briefly discusses the genetic contribution to varied responses to asthma therapy for four common types of asthma medications: β-agonists, anticholinergics, leukotriene modifiers, and corticosteroids. © 2008 Humana Press, a part of Springer Science + Business Media, LLC.

Cite

CITATION STYLE

APA

Hawkins, G. A., & Peters, S. P. (2008). Pharmacogenetics of asthma. Methods in Molecular Biology, 448, 359–378. https://doi.org/10.1007/978-1-59745-205-2_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free